காப்புரிமை பெற்றது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from காப்புரிமை பெற்றது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In காப்புரிமை பெற்றது Today - Breaking & Trending Today

Clinical trials to test research showing NZ milk can help in Covid-19 fight

Clinical trials to test research showing NZ milk can help in Covid-19 fight
10 Mar, 2021 04:00 PM
3 minutes to read
Dr Rod Claycomb, founder of Hamilton s Quantec, and chief executive Raewyn McPhillips. Photo / Supplied
A Hamilton biotech company is to start clinical trials after research showed its New Zealand milk-derived patented ingredient is effective in Covid-19 protection.
Quantec said research, completed by an independent US laboratory, showed its ingredient
IDP (Immune Defence Proteins) had the ability to protect cells from Covid-19, but may also reduce the severity of the virus symptoms, a key concern for sufferers of long Covid .
Chief executive Raewyn McPhillips said the clinical trials would likely be held in New Zealand and China. ....

New Zealand , Raewyn Mcphillips , Immune Defence Proteins , Covid 19 , புதியது ஜீலாந்து , நோய் எதிர்ப்பு சக்தி பாதுகாப்பு ப்ரோடீந்ஸ் , காப்புரிமை பெற்றது ,

Stock Day Media: Arizona Silver Exploration, Inc. Discusses Progress of Perry Patented Claim Property with The Stock Day Podcast

(2)
Phoenix, Arizona (Newsfile Corp. - March 10, 2021) -
The Stock Day Podcast welcomed Arizona Silver Exploration, Inc. (OTCQB: AZASF) ( the Company ), a publicly traded company engaged in junior mining exploration primarily in the Western United States. CEO of the Company, Mike Stark, joined Stock Day host Everett Jolly.
Jolly began the interview by asking about the progress of the Company s current drill program. We re at less than 10% of our total 21 claims that we re exploring at this time, and we ve had significant hits. As a matter of fact, we re at about an 86% hit rate ranging from as little as 1 to 41 grams gold, shared Stark. We re chasing a high-grade vein here, he added. We ve yet to see the limits here and we continue to explore outward. ....

United States , Mike Stark , Everett Jolly , Arizona Newsfile Corp , Arizona Silver Exploration Inc , Arizona Silver Exploration Co , Venture Exchange , Regulation Services Provider , Stock Day Podcast , Arizona Silver Exploration , Western United , Stock Day , Walker Lane Trend , Perry Patented Claim , Ramsey Silver , Stock Day Media , Silver Exploration , United States Securities Act , ஒன்றுபட்டது மாநிலங்களில் , மைக் அப்பட்டமான , எவரெட் மகிழ்ச்சி , அரிசோனா வெள்ளி ஆய்வு இன்க் , அரிசோனா வெள்ளி ஆய்வு இணை , துணிகர பரிமாற்றம் , ஒழுங்குமுறை சேவைகள் வழங்குநர் , ஸ்டாக் நாள் பொட்கஸ்ட் ,

America's Cup 2021: Advantage Luna Rossa? Team New Zealand skipper Glenn Ashby's hint about rival's 'patented' strategy

America s Cup 2021: Advantage Luna Rossa? Team New Zealand skipper Glenn Ashby s hint about rival s patented strategy
4 Mar, 2021 02:00 AM
3 minutes to read
American Magic Helmsman Dean Barker and AUT Sailing Professor Mark Orams join Matt Brown to discuss all of the latest news ahead of the 36th America s Cup. Video / NZ Herald
American Magic Helmsman Dean Barker and AUT Sailing Professor Mark Orams join Matt Brown to discuss all of the latest news ahead of the 36th America s Cup. Video / NZ Herald
NZ Herald
Team New Zealand trimmer Glenn Ashby has hinted that they are mixing it up on the water, but the defenders are still keeping their cards close to their chest about potentially using their rival s patented strategy. ....

United States , New Zealand , United Kingdom , New Zealanders , Jimmy Spithill , Luna Rossa , Max Sirena , Glenn Ashby , Peter Burling , Team New Zealand , While Team , Sky Sport , Frencesco Bruni , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஜீலாந்து , ஒன்றுபட்டது கிஂக்டம் , லூனா ரோசா , அதிகபட்சம் சிரென , க்ளென் ஆஷ்பி , பீட்டர் பர்லிங் , அணி புதியது ஜீலாந்து , போது அணி , வானம் விளையாட்டு , காப்புரிமை பெற்றது ,

ESR Reimagines MagSafe Charging with its Patented Design

ESR Reimagines MagSafe Charging with its Patented Design
WILMINGTON, Del., Feb. 25, 2021 /PRNewswire/ Global tech company ESR released its HaloLock Kickstand Wireless Charger ($35.99), redefining the MagSafe charging experience. This new addition to its HaloLock series leverages ESR s patented adjustable kickstand, giving it the unique ability to transform on demand from a pad to a stand charger.
In October 2020, ESR released the world s first MagSafe car charger. The market response was resounding and the charger quickly became a bestseller, said ESR CEO Tim Wu. People are excited about MagSafe and we continue to believe that small but meaningful design changes can make new technology like MagSafe radically more intuitive. By adapting the patented kickstand from our popular phone cases, we ve given users more ways to use MagSafe than a standard charger allows. ....

Kostenloser Wertpapierhandel , Tim Wu , Halolock Kickstand Wireless Charger , Lock Kickstand Wireless , Apple Magsafe , Wireless Charging Stand , Wireless Charger , Wireless Car Charger , நேரம் வு , பூட்டு கிக்கக்ஸ்தண்ட் வயர்லெஸ் , வயர்லெஸ் கட்டணம் வசூலிக்கிறது நிற்க , வயர்லெஸ் சார்ஜர் , வயர்லெஸ் கார் சார்ஜர் , காப்புரிமை பெற்றது ,

Enzolytics, Inc.: Enzolytics Inc. Reports Test Results of its Patented ITV-1 Conducted at the National Centre of Infectious and Parasitic Diseases

(2)
COLLEGE STATION, TX / ACCESSWIRE / February 16, 2021 / Enzolytics, Inc. (OTC PINK:ENZC) (the Company ) announced today the results of an
in vitro study of the Company s ITV-1/IPF peptide treatment that demonstrated the broad efficacy with low toxicity. The Company s ITV-1 peptide was tested against human corona virus 229E Strain (HCoV-229E) and exhibited comparable efficacy but with a 20-fold lower toxicity than the widely used anti-influenza medicine Tamiflu
®.
Currently, the ITV-1/IPF therapeutic is being scheduled for further clinical trials to establish the breath of efficacy of the therapeutic. The just completed study was conducted by Professor Petia Genova-Kalou, at the National Centre of Infectious and Parasitic Diseases in Sofia, Bulgaria. In the study, the antiviral capability of Enzolytics ITV-1/IPF peptide inhibitor was measured in comparison to oseltamivir phosphate (Tamiflu®) in an ....

United States , Sofiya Grad , Kostenloser Wertpapierhandel , Petia Genova Kalou , Harry Zhabilov , While Enzolytics Inc , Texasam University , Bioclonetics Immunotherapeutics Inc , Drug Administration , Research Center , National Centre Of Infectious , Enzolytics Inc , Institute For Preclinical , Professor Petia Genova Kalou , National Centre , Parasitic Diseases , Immune Therapeutic , Inactivated Pepsin Fraction , College Station , Harbor Statement , ஒன்றுபட்டது மாநிலங்களில் , சோஃபியா கிரத் , ஆராய்ச்சி மையம் , தேசிய மையம் ஆஃப் தொற்று , தேசிய மையம் , ஒட்டுண்ணி நோய்கள் ,